Arunjyoti Bio

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE485K01022
  • NSEID:
  • BSEID: 530881
INR
6.55
0.31 (4.97%)
BSENSE

May 06

BSE+NSE Vol: 15.78 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 685046,
    "name": "Arunjyoti Bio",
    "stock_name": "Arunjyoti Bio",
    "full_name": "Arunjyoti Bio Ventures Ltd",
    "name_url": "stocks-analysis/arunjyoti-bio",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6.55",
    "chg": 0.31,
    "chgp": "4.97%",
    "dir": 1,
    "prev_price": "6.24",
    "mcapval": "122.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530881,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE485K01022",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "15.78 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arunjyoti-bio-685046-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3966411",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ArunjyotiBioVen_mojoScore_3966411.png",
        "date": "2026-04-28 10:10:39",
        "description": "Arunjyoti Bio Ventures Ltd is rated 'Strong Sell' by MarketsMOJO, a rating that was last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3950606",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ArunjyotiBioVen_mojoScore_3950606.png",
        "date": "2026-04-17 10:10:58",
        "description": "Arunjyoti Bio Ventures Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3934252",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ArunjyotiBioVen_mojoScore_3934252.png",
        "date": "2026-04-06 10:10:15",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 06 April 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3917898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ArunjyotiBioVen_mojoScore_3917898.png",
        "date": "2026-03-26 10:10:14",
        "description": "Arunjyoti Bio Ventures Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3892174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ArunjyotiBioVen_mojoScore_3892174.png",
        "date": "2026-03-15 10:10:12",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 15 March 2026, providing investors with the latest comprehensive view of the company’s position."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3866247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ArunjyotiBioVen_mojoScore_3866247.png",
        "date": "2026-03-03 10:10:23",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3848222",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ArunjyotiBioVen_mojoScore_3848222.png",
        "date": "2026-02-20 10:10:20",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 20 February 2026, providing investors with the latest comprehensive view of the company’s position."
      },
      {
        "title": "Arunjyoti Bio Ventures Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arunjyoti-bio-ventures-ltd-is-rated-strong-sell-3828441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ArunjyotiBioVen_mojoScore_3828441.png",
        "date": "2026-02-09 10:10:52",
        "description": "Arunjyoti Bio Ventures Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Arunjyoti Bio Ventures Gains 10.04%: Key Financial Trends and Market Moves This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arunjyoti-bio-ventures-gains-1004-key-financial-trends-and-market-moves-this-week-3826432",
        "imagepath": "",
        "date": "2026-02-07 16:03:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens at Rs.7.16, up 1.27% despite Sensex decline</p>\n                    <p><strong>3 Feb:</strong> Q3 FY26 results reveal profitability pressures; stock dips 1.26%</p>\n                    <p><strong>4 Feb:</strong> Flat quarterly performance reported; stock rebounds 4.10%</p>\n                    <p><strong>5 Feb:</strong> Strong volume supports 1.90% gain amid mixed market</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.7.78, up 3.73% on positive momentum</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n        ..."
      }
    ],
    "total": 345,
    "sid": "685046",
    "stock_news_url": "https://www.marketsmojo.com/news/arunjyoti-bio-ventures-685046"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Board Meeting To Be Held On 08.05.2026.",
      "datetime": "01-May-2026",
      "details": "Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financials results for the Quarter and Year ended 31.03.2026.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Arunjyoti Bio Ventures Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L01400TG1986PLC062463</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Swati Jain</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Vishal Nadimpalli</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Arunjyoti Bio Ventures Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L01400TG1986PLC062463</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>20.57</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Swati Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cenport@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vishal Nadimpalli <br/> Designation: CFO <br/> EmailId: cenport@gmail.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Arunjyoti Bio Ventures Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Jan 25",
          "dt": "2025-01-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Board Meeting To Be Held On 08.05.2026.

01-May-2026 | Source : BSE

Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financials results for the Quarter and Year ended 31.03.2026.

Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

30-Apr-2026 | Source : BSE

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Arunjyoti Bio Ventures Ltd
2 CIN NO. L01400TG1986PLC062463
3 Report filed for FY 2025-2026
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 2025-26 2026-27
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)2024-25 2025-26
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Swati Jain
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- Vishal Nadimpalli
Designation : -CFO

Date: 30/04/2026

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

30-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyArunjyoti Bio Ventures Ltd
2CIN NO.L01400TG1986PLC062463
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 20.57
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Swati Jain
Designation: Company Secretary and Compliance Officer
EmailId: cenport@gmail.com
Name of the Chief Financial Officer: Vishal Nadimpalli
Designation: CFO
EmailId: cenport@gmail.com

Date: 30/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

12 May 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Arunjyoti Bio Ventures Ltd has announced 1:10 stock split, ex-date: 17 Jan 25

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available